Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Even Healthy Lungs Labor At Acceptable Ozone Levels
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.

FDA Approves First Canine Cancer Therapy
Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved the first canine cancer therapy in the U.S. - PALLADIATM (toceranib phosphate) - which was developed by Pfizer to treat mast cell tumors in dogs. Pfizer made the announcement to veterinarians attending the 2009 American College of Veterinary Internal Medicine (ACVIM) Forum and Canadian Veterinary Medical Association Convention.
News of the day
Neurocrine Announces Full Year Results From 603 Study (Petal Study) Of Elagolix For Treatment Of Endometriosis Pain
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced additional positive safety and efficacy results from its Phase IIb clinical trial known as the Petal Study (603 study) using its proprietary, orally-active non-peptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. The Petal Study enrolled 252 patients, with a confirmed diagnosis of endometriosis, into three treatment groups; elagolix 150 mg once daily, elagolix 75 mg twice daily, or depo-subQ provera 104(TM) (DMPA) for six months of treatment followed by six months of no treatment. Database lock and unblinding of the full 48 week data set has provided more insight on the clinical benefits and safety profile of elagolix for the treatment of pain associated with endometriosis.
Medical Devices

RCN Responds To Publication Of Lord Darzi's Progress Report

Responding to the publication of Lord Darzi"s report, High Quality Care for All: Our Journey So Far, Dr Peter Carter, Chief Executive & General Secretary of the Royal College of Nursing (RCN), said: "Nurses have always strived to deliver quality care and welcomed Lord Darzi"s vision for how clinical staff could achieve this. It has been a significant achievement that since the publication of the NHS review a year ago, everybody is talking about how quality of patient care should take centre stage in the NHS. However, in the tough economic climate we must not take our eye off the ball and let the focus on quality slip. If we are to make quality a reality rather than an aspiration, it is vital that nurses are empowered and given the right level of support. "We have always said clinical leadership is key to driving up patient care and welcome the news that nurses are set to have greater control over budgets. Their frontline perspective means nurses know where money should be spent to achieve the best care for patients. However, adequate support and training for these professionals is needed, particularly while the threat of public spending cuts looms. "While there have been significant improvements in the NHS, there are certain areas where further work is needed. There needs to be greater clarification regarding the practicalities of what delivering care closer to home would look like. Patients want to know exactly what services will be available in the area they call home." "If genuine improvements to the NHS are to be achieved, significant progress towards delivering Darzi"s promises must be made, and the new ways of working must be embedded, before the financial pressures take hold." Royal College of Nursing


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009